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INTRODUCTION
Malignancy of the biliary hilum (e.g., hilar cholangiocarcinoma, and gallbladder cancer with hilar invasion) has an extremely poor prognosis, with a 5-year survival rate of less than 10% (1, 2) . Most of the cases are known to be inoperable and the reported resectability rate of hilar bile duct tumor is approximately 10-20% (3) . Thus, the majority of patients receive just palliative treatment.
Following the development of the T-configured dual stent, single percutaneous transhepatic approach for bilateral drainage has been widely used in the field of interventional radiology (4).
More recently, the endoscopic Y-stent, a novel variant of the T-configured stent, is being widely used for bilateral internal drainage of malignant hilar obstruction (5) (6) (7) (8) . The technical success rate and the patency of the endoscopic Y-stent are reported to be similar to those of percutaneous approaches (5) .
Cotton et al. (9) defined an early complication as any stent-re-the PTBD tract several days after the PTBD. The mean time of rescue stenting after PTBD was 7.3 days (range 2-13 days). Metallic stents were placed through the stenotic or obstruction lesions in all patients. The technique used to place stents is illustrated in Figs. 1 and 2 .
Endoscopic Y-stenting was performed in patient 1 who had malignant hilar obstruction due to gallbladder cancer with hilar invasion (Fig. 1A) . But after the procedure, patient 1 had fever and jaundice caused by a second stent insertion failure. And on cholangiogram, obstruction at the right hepatic duct was identified ( Fig. 1B) . 0.035-inch 150-cm long hydrophilic guide wires (Terumo, Tokyo, Japan) were negotiated through the endoscopically induced strictures and stent meshes into the common bile duct (CBD), and both wires were dilated by a balloon catheter over the guide wire ( Fig. 1C, D) . Rescue stents were deployed through the mesh of the endoscopic stents and CBD. Following stent deployment, an 8.5-Fr drainage catheter (Uresil, Skokie, IL, USA) was placed over the guide wire. Three days after stent placement, contrast material was injected to confirm the position and patency of the rescue stents, and the PTBD catheters were removed ( Fig. 1E ).
Obstructive jaundice after endoscopic Y-stenting occurred due to a second stent malposition in patient 2. And rescue stenting at the right hepatic duct was performed with the same technique described as above ( Fig. 2 ).
Broad spectrum antibiotics were given to patients before and after each procedure. All of the rescue stenting was performd by one experienced interventional radiologist (C.W.K.).
The outcome of rescue stenting was evaluated using the fol- Early obstruction with biliary sepsis can be particularly fatal.
Hwang et al. (6) reported that the early complication rate of endoscopic Y-stenting is 10%. In their study, all of the early complications observed were infectious ones and were accompanied by obstructive jaundice. And percutaneous transhepatic biliary drainage (PTBD) is required in cases of an infectious complication caused by obstructive jaundice.
In general, patients with stent malfunction undergo PTBD, and thus, internal drainage cannot be achieved.
To manage the early failure of endoscopic biliary stenting, we applied percutaneous transhepatic stenting as a rescue for internal drainage. The purpose of this study is to evaluate the feasibility and effectiveness of percutaneous transhepatic stenting as a rescue for the early occlusion of endoscopic biliary stents.
MATERIALS AND METHODS
We retrospectively studied ten patients (4 men and 6 women; The results of all of the cases were consistent with the definition of early endoscopic stent failure. Mean time to endoscopic stent failure was 13.5 days (range 4-45 days). Causes of early endoscopic stent failure included second stent (endoscopic Ystent) insertion failure (n = 5) ( Fig. 1) , malposition of the second stent in B4 (n = 2) ( Fig. 2 ), partial drainage due to an anatomical variation (n = 1) and tumor invagination through the stent mesh (n = 2). Tumor invagination was defined as narrowing of the stent lumen on cholangiogram, and tumor within the stent lumen as seen on CT or MR. The mean time of rescue stenting after PTBD was 7.3 days (range 2-13 days) ( Table 1) . days from the second drainage to reintervention or the patient's death. Survival time was defined as the interval between the time of rescue stenting and the patient's death.
Statistical analyses were performed using commercially available software (SPSS 10.0; SPSS Inc., Chicago, IL, USA). The rates of stent patency and survival were calculated using the Kaplan-Meier method.
Informed consent was obtained from all patients before the procedures. Certification of the Institutional Review Board was waived for this retrospective study.
RESULTS
In this study, two patients had gallbladder cancer with hilar in- The results of our rescue stenting showed shorter patency and survival times in comparison with the results of primary transhepatic stenting for malignant hilar obstruction using T-configured dual stents (mean patency 170.3 days) (4). There were several causes of the worse outcome in rescue stenting. In this study, the most common cause of early failure in endoscopic Y-stenting was technical problems, such as second stent insertion failure, stent malposition and partial drainage due to anatomical variation. It seems that the unsuitable positioning of the primary endoscopic stents due to technical problems led to the worse outcome. Rescue stenting itself is technically more difficult than primary transhepatic stenting. Also most of the patients with early endoscopic Ystents already had infectious complications (such as infectious cholangitis) by the time they received the rescue stents, which could have also contributed to the differences in the outcome.
Transhepatic rescue stenting is a kind of new procedure. And it was technically feasible in our study. There is no other solution for early failure of endoscopic stents except for a PTBD procedure.
Though rescue stenting has no definite survival benefit, it makes internal drainage possible after the early failure of endoscopic
